Novel neuromuscular blocking drugs and antagonists Review uri icon

Overview

MeSH Major

  • Cysteine
  • Isoquinolines
  • Neuromuscular Blockade
  • Neuromuscular Nondepolarizing Agents

abstract

  • The gantacurium derivative CW002 is an intermediate duration, nondepolarizing, cysteine-inactivated, neuromuscular blocking drug currently in clinical trials. Like sugammadex reversal of rocuronium, CW002 can be reversed at any time by cysteine injection.

publication date

  • January 2015

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/ACO.0000000000000209

PubMed ID

  • 26087274

Additional Document Info

start page

  • 403

end page

  • 10

volume

  • 28

number

  • 4